ROCHE HOLDING AG SIX:RO:
LAUNCHES NEXT GENERATION SEQUENCING PLATFORM AXELIOS 1
WILL PURSUE DEVELOPMENT OF A ROADMAP FOR CLINICAL MARKET
AXELIOS 1 PLATFORM IS PRICED AT $750,000 IN THE US
ANTICIPATES GLOBAL RESEARCH USE ONLY COMMERCIAL RELEASE IN SUMMER 2026
INITIAL FOCUS ON NORTH AMERICA AND SELECT MARKETS IN EUROPE AND APAC